Come up with a name for your new list and we'll add to it:
Scynexis raised a round of funding on November 26, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Scynexis is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. The company is developing it…